BSBE has teamed up with National Pharmaceutical Investment to acquire MXB for $371 million. In a separate development, new material company Mingxun Hi-Tech Material Joint-Stock has raised ‘tens of millions of US dollars’ in a new funding round from Fosun, Addor Capital and Cowin Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com